Keyphrases
COVID-19
100%
Coronavirus Disease (COVID)
100%
Severe Acute Respiratory syndrome-CoV-2
100%
Coronavirus
66%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
66%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
66%
Ebola Virus
66%
Early Diagnosis
33%
Antiviral Drugs
33%
Confirmed Cases
33%
China
33%
Virus
33%
Preventive Measures
33%
High Transmission
33%
Viral Infection
33%
Zika Virus
33%
Transmissibility
33%
Human-to-human Transmission
33%
Quantitative PCR
33%
New Disease
33%
Wuhan City
33%
Pandemic Virus
33%
Antiviral Vaccines
33%
Emerging Viruses
33%
Zoonotic Origin
33%
Emerging Viral Disease
33%
Animal Hosts
33%
Previous Experience
33%
Animal Sources
33%
Novel Virus
33%
Nipah Virus
33%
Codon Usage
33%
Usage Studies
33%
Diagnostic Aspects
33%
Epidemiological Aspects
33%
Genome Sequencing
33%
Low Pathogenic
33%
Next-generation Sequencing
33%
Clinical Aspects
33%
H7N9
33%
Potential Therapeutic Strategies
33%
Therapeutic Aspects
33%
Human Coronavirus (HCoV)
33%
Immunology and Microbiology
COVID-19
100%
Viral Disease
100%
Severe Acute Respiratory Syndrome
100%
Infectious Agent
100%
Coronavirus
100%
Coronavirinae
100%
Ebola Virus
100%
Middle East Respiratory Syndrome Coronavirus
100%
SARS Coronavirus
100%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Real Time Polymerase Chain Reaction
50%
Zoonotic
50%
Emerging Viruses
50%
Codon Usage
50%
Bird
50%
Severe Acute Respiratory Syndrome Coronavirus
50%
Next Generation Sequencing
50%
Influenza A Virus (H7N9)
50%
Zika Virus
50%
Pathogenicity
50%
Coronaviridae
50%
Nipah Virus
50%
Genome Sequencing
50%
Medicine and Dentistry
Disease
100%
Coronavirinae
100%
COVID-19
66%
Severe Acute Respiratory Syndrome
66%
Virus Infection
66%
Pathogen
66%
Coronavirus
66%
SARS Coronavirus
66%
Ebolavirus
66%
Middle East Respiratory Syndrome Coronavirus
66%
Diagnosis
33%
Early Diagnosis
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Zika Virus
33%
Real Time Polymerase Chain Reaction
33%
Emerging Viruses
33%
Avian Virus
33%
Genome Sequencing
33%
Influenza A Virus (H7N9)
33%
Pathogenicity
33%
Codon Usage
33%
Next Generation Sequencing
33%
Coronaviridae
33%
Antivirus Agent
33%
Severe Acute Respiratory Syndrome Coronavirus
33%
Virus Vaccine
33%
Nipah Virus
33%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Coronavirinae
100%
Severe Acute Respiratory Syndrome
60%
Infectious Agent
40%
SARS Coronavirus
40%
Virus Infection
40%
Middle East Respiratory Syndrome Coronavirus
40%
Ebola Virus
40%
Bird
20%
Zika Virus
20%
Antivirus Agent
20%
Virus Vaccine
20%
Influenza A Virus (H7N9)
20%
Nipah Virus
20%
Coronaviridae
20%
Pathogenicity
20%